Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
76.25
+0.98 (1.30%)
At close: Sep 26, 2025, 4:00 PM EDT
76.71
+0.46 (0.60%)
After-hours: Sep 26, 2025, 7:56 PM EDT
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $44.77 billion as of September 26, 2025. Its market cap has increased by 8.96% in one year.
Market Cap
44.77B
Enterprise Value
41.40B
1-Year Change
8.96%
Ranking
Category
Stock Price
$76.25
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $44.77B, an increase of 4,570.46%. That is a compound annual growth rate of 16.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 44.77B | 2.53% |
Dec 31, 2024 | 43.66B | -5.51% |
Dec 29, 2023 | 46.21B | 0.17% |
Dec 30, 2022 | 46.13B | -42.97% |
Dec 31, 2021 | 80.88B | 42.25% |
Dec 31, 2020 | 56.86B | 16.86% |
Dec 31, 2019 | 48.66B | 51.96% |
Dec 31, 2018 | 32.02B | 34.25% |
Dec 29, 2017 | 23.85B | 19.05% |
Dec 30, 2016 | 20.03B | 17.59% |
Dec 31, 2015 | 17.04B | 25.03% |
Dec 31, 2014 | 13.63B | 89.40% |
Dec 31, 2013 | 7.19B | -30.86% |
Dec 31, 2012 | 10.41B | 29.03% |
Dec 30, 2011 | 8.06B | -12.62% |
Dec 31, 2010 | 9.23B | 87.85% |
Dec 31, 2009 | 4.91B | 60.64% |
Dec 31, 2008 | 3.06B | 17.27% |
Dec 31, 2007 | 2.61B | -4.23% |
Dec 29, 2006 | 2.72B | 10.05% |
Dec 30, 2005 | 2.47B | 0.91% |
Dec 31, 2004 | 2.45B | 37.56% |
Dec 31, 2003 | 1.78B | 16.52% |
Dec 31, 2002 | 1.53B | -6.49% |
Dec 31, 2001 | 1.64B | 57.15% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 650.45B |
Johnson & Johnson | 432.80B |
AbbVie | 389.72B |
UnitedHealth Group | 311.62B |
Novo Nordisk | 242.68B |
Novartis AG | 238.65B |
Abbott Laboratories | 232.44B |
AstraZeneca | 228.75B |